2 weeks OraSure: An NCAV Diamond In The COVID RoughSeeking Alpha

OraSure: An NCAV Diamond In The COVID Rough.

Coronavirus

15 hours 60% of Americans aren’t getting the updated COVID vaccine: Here’s who’s opting out and whyFast Company X

1 day Is It Time to Sell Eli Lilly and Pfizer Stocks?The Motley Fool X

2 days COVID-19 virus may have a surprising benefit — it might be able to shrink certain tumorsMarketWatch X

2 days Best Oil Stocks Right NowBenzinga X

2 days UK startup taps last-mile delivery algorithms to bring a nurse to youThe Next Web X

4 days Where Will Teladoc Be in 5 Years?The Motley Fool X

6 days Pfizer- am I stuck with take lock or is this a great value?Reddit X

6 days United, Delta and Alaska Air are the buys in ‘mixed’ air-travel recovery, says Goldman analystMarketWatch X

6 days Prediction: The Fed’s Rate Cuts Will Lead to Lower Home Prices in 2025The Motley Fool X

6 days I’m a Costco Superfan, but Here’s Why I Almost Never Shop on Costco.comThe Motley Fool X

6 days Court Hears New York Times Case Against European Commission Over Vaccine DealThe New York Times X

7 days Has Gold Lost Its Luster?The Wall Street Journal X

7 days 10 Most Undervalued Hotel Stocks To Invest In NowInsider Monkey X

7 days Is Pfizer Stock A Sell After Covid Products Drive Third-Quarter Upside?Investor's Business Daily X

1 week Novavax cuts 2024 revenue forecast again on lower COVID vaccine salesInvesting.com X

2 weeks AMC saw tailwinds from blockbuster movies, but one problem lingersTheStreet X

2 weeks 10 Best Internet Retail Stocks to Buy NowInsider Monkey X

2 weeks Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take holdYouTube X

2 weeks Moderna reports surprise profit on higher-than-expected COVID vaccine salesYahoo Finance X

2 weeks The Smartest Dividend Stock to Buy With $10,000 Right NowThe Motley Fool X

2 weeks Gilead Sprints To A Profit-Taking Zone After Riding Covid Drug To Beat And RaiseInvestor's Business Daily X

2 weeks Gilead’s third-quarter earnings beat by a wide margin, and biotech raises guidanceMarketWatch X

2 weeks Nintendo is struggling to sell a product that was once sold outTheStreet X

2 weeks UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US StocksInsider Monkey X

2 weeks Goldman Sachs sees rate cuts, but elections make things tricky for 2025TheStreet X

2 weeks AMC’s third-quarter results on deck amid signs of a cinema-industry reboundMarketWatch X

2 weeks Arcturus Gears Up to Report Q3 Earnings: Here’s What to ExpectZacks X

2 weeks TGI Fridays bankruptcy update: Will more restaurant locations close amid Chapter 11?Fast Company X

3 weeks TGI Fridays files for bankruptcy, as sit-down chain restaurants face challengesCBS News X

3 weeks This Idaho Health Department Has Stopped Providing COVID-19 VaccinesInc.com X

3 weeks COVID-19 is no longer the world’s leading infectious disease killerFortune X

3 weeks VW’s Profitability Is the Lowest Since the Covid-19 PandemicYouTube X

3 weeks Jefferies’ Top Crowded Semiconductor Long Positions: Top 10 StocksInsider Monkey X

3 weeks Pfizer profit up on COVID treatment sales as it faces activist pressureInvesting.com X

3 weeks BP beats forecasts despite seeing 31% drop in profits, to lowest since COVID-19MarketWatch X

3 weeks Will Non-COVID Drugs Again Boost Pfizer’s Top Line in Q3 Earnings?Zacks X

4 weeks On Navajo Nation, a push to electrify more homes on the vast reservationMarketBeat X

4 weeks Joseph Gagnon On The Trinity Of COVID-Era Inflation And The Upcoming Fed Framework ReviewSeeking Alpha X

4 weeks AptarGroup CEO: Consumer is still there, but our numbers reflect inventory adjustments post-COVIDYouTube X

4 weeks 10 Best Airline Stocks to Buy According to Hedge FundsInsider Monkey X

4 weeks This company redesigned the underwire bra to actually be comfortableFast Company X

4 weeks Las Vegas Sands misses Q3 estimates with visitation to Macao below pre-COVID levelsInvesting.com X

4 weeks The Best Pharmaceutical Stock to Invest $1,000 in Right NowThe Motley Fool X

4 weeks Pneumonia can be a deadly complication of COVID, the flu, and RSV: What to know about pneumococcal vaccinationFortune X

1 month EPR Properties Rebounds: Here’s How to Cash In on a 7% YieldInvestors Alley X

1 month Southwest’s Lead From COVID Has Dissipated, And Now They Face The ConsequencesSeeking Alpha X

1 month How Bad Is This News for Novavax?The Motley Fool X